A new study shows that, depending on the parasite stage, suboptimal doses of artemisinin could increase its conversion to the sexual form, which is the only form that can be transmitted
Read moreBHV Partners, the first venture builder in the southern European health sector, has moved its headquarters to the Barcelona Science Park, and closes an investment round, raising half a million euros. ...
Read moreLa crisis del coronavirus Covid-19 está suponiendo un gran desafío para la forma en que las organizaciones captan, evalúan, desarrollan y conservan su talento directivo, generando un entorno compet...
Read moreMinoryx Therapeutics, a Phase 3 clinical stage biotech company focused on the development of differentiating treatment options in orphan central nervous system (CNS) disorders, today announces that th...
Read moreSartorius, a leading international partner of life science research and the biopharmaceutical industry, is expanding its presence in Massachusetts with a North American Customer Interaction Center. Sa...
Read moreLas redes de vigilancia médica que funcionan para monitorizar otras enfermedades podrían apoyar el control epidemiológico del SARS-CoV-2. Pero para ello harían falta más recursos destinados a la ...
Read moreAzbil Corporation announced it has established new numerical targets for essential goals of the Group in the field of Sustainable Development Goals (SDGs). In pursuit of achieving a sustainable societ...
Read moreThe life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the ...
Read moreDesde el pasado mes de marzo, la sociedad en general, y sectores específicos como las funerarias, en particular, estamos viviendo unos tiempos ciertamente complicados.
Read moreA team of researchers led by Timothy Thomson's group from the Barcelona Institute of Molecular Biology (IBMB-CSIC), based at the Barcelona Science Park, has developed a platform that allows to see i...
Read more